Gene Therapy of Salivary Diseases

Bruce J Baum1,2, Sandra Afione3, John A Chiorini3

  • 1Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda, MD, 20892, USA. bbaum@dir.nidcr.nih.gov.

Insights

Researchers developed gene transfer methods for salivary gland disorders, focusing on irradiation-induced salivary hypofunction. This chapter details transgene and vector selection, viral vector construction, delivery, and functional assessment in animal models.

Area of Science:

  • * Gene therapy
  • * Molecular biology
  • * Regenerative medicine

Background:

  • * Salivary gland disorders often lack effective conventional treatments.
  • * Gene transfer offers a promising therapeutic avenue for these conditions.
  • * Previous work established foundational gene transfer methods in 2010.

Purpose of the Study:

  • * To update and describe key gene transfer methods for salivary gland disorders.
  • * To focus on irradiation-induced salivary hypofunction as a model condition.
  • * To provide a comprehensive overview of the gene transfer process.

Main Methods:

  • * Selection of appropriate transgenes and viral vectors.
  • * Construction of recombinant viral vectors.
  • * Methods for vector delivery and in vitro/in vivo functional assessment.
  • * Utilization of a relevant animal model for evaluating vector efficacy.

Main Results:

  • * Detailed methodologies for gene transfer are presented.
  • * The chapter outlines strategies for overcoming challenges in salivary gland gene therapy.
  • * Established protocols for assessing vector performance are described.

Conclusions:

  • * Gene transfer represents a viable strategy for treating salivary gland hypofunction.
  • * The described methods provide a framework for advancing salivary gland regenerative medicine.
  • * Continued research and refinement of these techniques are crucial for clinical application.